The global preeclampsia diagnostics market size was valued at USD 1.03 billion in 2021 and reached USD 1.07 billion in 2022. The market is expected to reach USD 1.24 billion by 2029, exhibiting a CAGR of 2.2% during the forecast period. The rising prevalence of preeclampsia and increasing technological advancements in diagnostics procedures are expected to foster industry growth. Fortune Business Insights™ presents this information in its report titled “Preeclampsia Diagnostics Market, 2022-2029.”

Key Industry Development

  • July 2021: LifeCell Diagnostics announced a comprehensive preeclampsia screening in India. The advanced screening detects biomarker, sFLT-1 (soluble FMS-like tyrosine kinase-1), which enables the prediction of the disease and helps in accurate diagnosis even in the third trimester.

Request a Sample Copy of the Research Report:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/preeclampsia-diagnostics-market-101519

Drivers and Restraints

Development of Innovative Preeclampsia Diagnostic Procedures to Propel Market Progress

Preeclampsia diagnostics are a set of diagnostic procedures designed to protect mothers and infants from preeclampsia disorders. The development of innovative preeclampsia diagnostic procedure is expected to enhance the adoption of the diagnostic procedure. The rising prevalence of the disorder in pregnant women across the globe is expected to enhance the diagnostics’ adoption. For example, as per the NCBI’s research published in July 2021, preeclampsia occurrence in France reached 8.5% among pregnant women. These factors may drive the preeclampsia diagnostics market growth.

However, lack of awareness regarding preeclampsia is expected to hinder the industry’s growth.

Click here to get the short-term and long-term impact of COVID-19 on this market.

Please visit:https://www.fortunebusinessinsights.com/industry-reports/preeclampsia-diagnostics-market-101519

COVID-19 Impact

Robust Demand from Healthcare Sector Fostered Market Progress

This market was positively impacted during the pandemic due to the rising demand for preeclampsia diagnostics procedures from the healthcare sector. The increasing cases of preeclampsia led to the procedure’s rapid adoption. Further, government guidelines such as amendments encouraging the adoption of such procedures are expected to enhance the demand for the product. Moreover, market players experienced a huge spike in revenues due to the procedure’s extensive adoption. For example, PerkinElmer Inc. experienced massive growth of 31.2% during 2020, reaching USD 3,782.8 million. These factors influenced the industry growth during the pandemic.

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd

U.S.: +1 424 253 0390

U.K.: +44 2071 939123

APAC: +91 744 740 1245

Email: [email protected]